腸骨ステントの世界市場

腸骨ステントの世界市場は2030年までに11億米ドルに達する見込み

2024年に9億1,670万米ドルと推定される腸骨ステントの世界市場は、分析期間2024-2030年にCAGR 3.4%で成長し、2030年には11億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである自己拡張型ステントタイプは、CAGR 2.6%を記録し、分析期間終了時には5億8,060万米ドルに達すると予測されます。バルーン拡張型ステントタイプの成長率は、分析期間中CAGR 4.5%と推定されます。

米国市場は2億4,970万米ドルと推定、中国はCAGR6.2％で成長予測

米国の腸骨ステント市場は、2024年に2億4,970万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR6.2％を引きずる形で、2030年までに2億2,080万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.4%と2.6%と予測されています。欧州では、ドイツがCAGR 1.9%で成長すると予測されています。

腸骨ステント：なぜ末梢動脈疾患と複雑な血管状態の管理に不可欠なのか？

世界の腸骨ステント市場- 主要動向と促進要因まとめ

腸骨ステントの世界市場は、末梢動脈疾患（PAD）の有病率の上昇、低侵襲血管インターベンションに対する需要の増加、ステント技術の継続的な進歩に後押しされ、大きな成長を遂げています。腸骨ステントは、骨盤や下肢に血液を供給する腸骨動脈の閉塞や狭窄（狭窄）の治療に使用されます。この病態はしばしばアテローム性動脈硬化症に起因しており、放置すると四肢の重大な虚血につながる可能性があります。腸骨ステントの需要は、高齢者や糖尿病、高血圧、高脂血症などの合併症を持つ患者に特に強く、血管合併症を起こしやすいです。

近年では、開腹手術による修復から血管内治療（EVT）への移行が見られ、中でも腸骨ステント留置術は罹患率が低く、入院期間が短く、回復が早いことから、ゴールドスタンダードとなりつつあります。市場の成長は、血管診断へのアクセスの増加、医療保険の適用拡大、世界のPADスクリーニングプログラムの増加によっても支えられています。これと並行して、特に高リスク集団における腸骨動脈疾患の早期発見と積極的治療に対する臨床医の意識が高まっています。このような力学が、先進国市場と新興国市場の両方で、ステント留置術と関連機器に対する旺盛な需要パイプラインを形成しています。

腸骨ステントのデザインと治療成績を向上させる技術革新とは？

ステントの設計と送達システムにおける技術進歩は、市場拡大の主要な促進要因です。特に腸骨分岐部のような複雑な解剖学的領域では、ステントの柔軟性、半径方向の強度、長期開存性を向上させるために、各メーカーが絶え間ない技術革新に取り組んでいます。一般にニチノール（ニッケルチタン合金）製の自己拡張型ステントは、その適合性と外部からの圧縮に対する抵抗性から、曲がりくねった動脈や移動性のある動脈で好まれています。一方、バルーン拡張型ステントは正確な留置が可能で半径方向の力が強いため、石灰化の激しい病変や限局性病変に適しています。両方のステントの利点を併せ持つハイブリッド型ステントも普及しつつあります。

薬剤溶出ステント（DES）はパクリタキセルやシロリムスなどの抗増殖剤を放出し、再狭窄率を低下させる画期的なものとして登場しました。DESは冠動脈に使用されるのが一般的であるが，良好な臨床成績から腸骨動脈を含む末梢での使用も拡大しています。さらに、後期ステント血栓症などの長期合併症を最小化するために、生体吸収性スキャフォールドやポリマーを含まないコーティングの開発が進められています。薄型カテーテルや親水性コーティングを含むデリバリーシステムの改良により、複雑な病変のナビゲーションが容易になり、手技時間も短縮されつつあります。このような技術革新により、腸骨ステント留置術はより安全で効率的、かつ耐久性の高いものとなり、同時に対象患者層も拡大しています。

腸骨ステントの需要はどこで伸びているのか？

北米と西欧が腸骨ステント市場を独占し続けているのは、高度なヘルスケアインフラ、PADの高い有病率、新しい血管技術の早期導入によるものです。特に米国は、血管内治療を支持する確固とした臨床ガイドラインとPAD治療に対する広範な償還制度があるため、主要市場となっています。ドイツ、フランス、英国などの欧州諸国も、高齢化社会と積極的な血管スクリーニングの取り組みによって、強い需要を示しています。

アジア太平洋地域は、中国、インド、日本が牽引する高成長市場として浮上しています。公衆衛生意識の高まり、インターベンショナル・カーディオロジーおよび放射線学サービスへのアクセス拡大、心血管危険因子の負担増加などの要因が、手技件数の増加を促しています。さらに、これらの地域の政府は第3次ヘルスケア施設の開発や地方へのアウトリーチプログラムに投資しており、PADの診断と介入へのアクセスを高めています。ラテンアメリカ、中東・アフリカの一部でも、医療ツーリズム、保険の普及、ヘルスケアのインフラが改善されるにつれて、徐々にPADの導入が進んでいます。どの地域でも、医師のトレーニングの増加や医療機器メーカーと病院との戦略的提携が、腸骨ステント留置技術の普及を加速させています。

腸骨ステント市場の成長はいくつかの要因によって牽引...

腸骨ステント市場の成長は、疾患の流行、技術の進歩、最終用途の拡大に関連するいくつかの要因によって牽引されています。主な促進要因は、人口動態の高齢化と喫煙、肥満、座りがちな行動などのライフスタイルに関連した危険因子によって煽られる末梢動脈疾患の世界の発生率の上昇です。PADがより一般的になるにつれて、腸骨ステントのような効果的な血行再建術の必要性は増加の一途をたどっています。さらに，超音波二重層法，CTアンギオグラフィ，MRアンギオグラフィなどの画像診断の改善により，腸骨動脈狭窄の早期かつ正確な同定が容易になってきています。

技術革新は依然として市場拡大の要です。送達性の向上、再狭窄の減少、より長い耐久性を提供する新しいステントプラットフォームの開発は、医師の嗜好を惹きつけ、臨床転帰を改善しています。最終用途も従来の血管センターだけでなく、外来クリニックや外来手術センターへと拡大しており、薄型で低侵襲のステントシステムの台頭がそれを可能にしています。さらに、良好な規制当局の承認、臨床試験のエビデンスの増加、血管内治療に対する支払者の支持の高まりが、より広範な採用を後押ししています。

最後に、価値観に基づく医療への移行、患者意識の向上、血管診断における人工知能の統合といった世界のヘルスケア動向は、腸骨動脈疾患の治療方法を再構築しつつあります。これらの動向は、PADの最前線治療薬としての腸骨ステントの戦略的重要性を強化し、地域、ヘルスケア環境、患者集団にまたがる持続的な需要を確実なものにしています。

セグメント

タイプ（自己拡張型ステントタイプ、バルーン拡張型ステントタイプ、カバードステントタイプ）;動脈病変（総腸骨動脈病変、重度石灰化動脈病変、完全閉塞性動脈病変）;エンドユーザー（病院エンドユーザー、外来手術センターエンドユーザー、その他エンドユーザー）

調査対象企業の例

• Abbott Laboratories
• Alvimedica
• B. Braun Melsungen AG
• Becton, Dickinson and Company（BD）
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• C. R. Bard, Inc.
• Cardinal Health, Inc.
• Cook Medical LLC
• Cordis Corporation
• Endologix LLC
• Getinge AB
• iVascular
• Jotec GmbH
• LeMaitre Vascular, Inc.
• Medtronic plc
• MicroPort Scientific Corporation
• OptiMed Medizinische Instrumente GmbH
• Terumo Corporation
• W. L. Gore & Associates, Inc.

AI統合

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Iliac Stents Market to Reach US$1.1 Billion by 2030

The global market for Iliac Stents estimated at US$916.7 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. Self-Expandable Stents Type, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$580.6 Million by the end of the analysis period. Growth in the Balloon-Expandable Stents Type segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$249.7 Million While China is Forecast to Grow at 6.2% CAGR

The Iliac Stents market in the U.S. is estimated at US$249.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$220.8 Million by the year 2030 trailing a CAGR of 6.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Iliac Stents: Why Are They Pivotal in Managing Peripheral Artery Disease and Complex Vascular Conditions?

Global Iliac Stents Market - Key Trends & Drivers Summarized

The global iliac stents market is experiencing significant growth, fueled by the rising prevalence of peripheral artery disease (PAD), increased demand for minimally invasive vascular interventions, and ongoing advancements in stent technology. Iliac stents are deployed to treat occlusions or narrowing (stenosis) in the iliac arteries, which supply blood to the pelvis and lower limbs. This condition often stems from atherosclerosis and can lead to critical limb ischemia if left untreated. The demand for iliac stents is particularly strong in elderly populations and patients with comorbidities such as diabetes, hypertension, and hyperlipidemia-conditions that predispose individuals to vascular complications.

Recent years have seen a shift from open surgical repair to endovascular treatment (EVT), with iliac stenting becoming the gold standard due to its lower morbidity, shorter hospital stays, and quicker recovery. Market growth is also being supported by increasing access to vascular diagnostics, expanded health insurance coverage, and a rising number of PAD screening programs globally. In parallel, there is growing awareness among clinicians regarding early detection and aggressive treatment of iliac artery disease, especially in high-risk populations. These dynamics are contributing to a strong demand pipeline for stenting procedures and related devices in both developed and emerging healthcare markets.

What Technological Innovations Are Enhancing Iliac Stent Design and Outcomes?

Technological advancement in stent design and delivery systems is a key driver of market expansion. Manufacturers are continuously innovating to improve stent flexibility, radial strength, and long-term patency-especially in complex anatomical regions like the iliac bifurcation. Self-expanding stents, typically made of nitinol (a nickel-titanium alloy), are favored in tortuous or mobile arteries due to their conformability and resistance to external compression. Balloon-expandable stents, on the other hand, offer precision placement and higher radial force, making them suitable for heavily calcified or focal lesions. Hybrid stents that combine the benefits of both designs are also gaining traction.

Drug-eluting stents (DES) have emerged as a game-changer, releasing antiproliferative agents such as paclitaxel or sirolimus to reduce restenosis rates. While DES are more commonly used in coronary arteries, their application in peripheral settings-including the iliac arteries-is expanding due to favorable clinical outcomes. In addition, bioresorbable scaffolds and polymer-free coatings are under development to minimize long-term complications such as late stent thrombosis. Improved delivery systems, including low-profile catheters and hydrophilic coatings, are making it easier to navigate complex lesions and reduce procedure time. These innovations are making iliac stenting safer, more efficient, and more durable, while expanding eligibility to broader patient populations.

Where Is Market Demand for Iliac Stents Growing - And What’s Driving It?

North America and Western Europe continue to dominate the iliac stents market, owing to advanced healthcare infrastructure, high prevalence of PAD, and early adoption of novel vascular technologies. The U.S., in particular, is a key market due to robust clinical guidelines supporting endovascular interventions and extensive reimbursement coverage for PAD treatment. European countries such as Germany, France, and the UK also exhibit strong demand, driven by aging populations and proactive vascular screening initiatives.

The Asia-Pacific region is emerging as a high-growth market, with China, India, and Japan leading the charge. Factors such as growing public health awareness, expanding access to interventional cardiology and radiology services, and a rising burden of cardiovascular risk factors are driving increased procedural volumes. Furthermore, governments in these regions are investing in the development of tertiary healthcare facilities and rural outreach programs, enhancing access to PAD diagnosis and intervention. Latin America, the Middle East, and parts of Africa are also witnessing gradual uptake as medical tourism, insurance penetration, and healthcare infrastructure improve. Across all regions, increasing physician training and strategic partnerships between medical device manufacturers and hospitals are accelerating the diffusion of iliac stenting technologies.

The Growth in the Iliac Stents Market Is Driven by Several Factors…

The growth in the iliac stents market is driven by several factors related to disease prevalence, technological advancement, and end-use expansion. A primary driver is the rising global incidence of peripheral artery disease, fueled by aging demographics and lifestyle-related risk factors such as smoking, obesity, and sedentary behavior. As PAD becomes more common, the need for effective revascularization options like iliac stents continues to increase. In addition, improvements in diagnostic imaging-such as duplex ultrasonography, CT angiography, and MR angiography-are facilitating early and accurate identification of iliac artery stenosis.

Technological innovation remains a cornerstone of market expansion. The development of new stent platforms-offering enhanced deliverability, reduced restenosis, and longer durability-is attracting physician preference and improving clinical outcomes. End-use applications are also expanding beyond traditional vascular centers to include outpatient clinics and ambulatory surgical centers, enabled by the rise of low-profile, minimally invasive stent systems. Furthermore, favorable regulatory approvals, increasing clinical trial evidence, and growing payer support for endovascular procedures are driving broader adoption.

Lastly, global healthcare trends-such as the shift toward value-based care, increased patient awareness, and integration of artificial intelligence in vascular diagnostics-are reshaping how iliac artery disease is treated. These trends are reinforcing the strategic importance of iliac stents as a frontline therapy for PAD and ensuring sustained demand across regions, healthcare settings, and patient populations.

SCOPE OF STUDY:

The report analyzes the Iliac Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Self-Expandable Stents Type, Balloon-Expandable Stents Type, Covered Stents Type); Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Artery Lesions, Complete Obstructive Artery Lesions); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Abbott Laboratories
• Alvimedica
• B. Braun Melsungen AG
• Becton, Dickinson and Company (BD)
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• C. R. Bard, Inc.
• Cardinal Health, Inc.
• Cook Medical LLC
• Cordis Corporation
• Endologix LLC
• Getinge AB
• iVascular
• Jotec GmbH
• LeMaitre Vascular, Inc.
• Medtronic plc
• MicroPort Scientific Corporation
• OptiMed Medizinische Instrumente GmbH
• Terumo Corporation
• W. L. Gore & Associates, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Iliac Stents - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Peripheral Arterial Disease Spurs Demand for Iliac Stents
  • Aging Population and Vascular Comorbidities Expand Addressable Market for Endovascular Therapies
  • Advancements in Stent Design and Coating Technologies Drive Product Innovation
  • Increasing Preference for Minimally Invasive Interventions Propels Iliac Stent Procedure Volume
  • Favorable Clinical Outcomes and Long-Term Patency Rates Strengthen Business Case for Iliac Stents
  • Expansion of Outpatient Vascular Surgery Centers Enhances Accessibility and Adoption
  • Technological Integration in Imaging and Navigation Systems Improves Placement Precision
  • Growing Use of Drug-Eluting Stents in Iliac Artery Treatments Accelerates Market Growth
  • Rising Awareness and Screening for Peripheral Vascular Disorders Throw Spotlight on Early Intervention
  • Clinical Guidelines Endorsing Endovascular Iliac Stenting Drive Physician Adoption
  • Product Innovation in Self-Expanding and Balloon-Expandable Stents Expands Therapeutic Options
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Iliac Stents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Iliac Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Iliac Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Iliac Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Self-Expandable Stents Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Self-Expandable Stents Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Self-Expandable Stents Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Balloon-Expandable Stents Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Balloon-Expandable Stents Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Balloon-Expandable Stents Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Covered Stents Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Covered Stents Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Covered Stents Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Common Iliac Artery Lesions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Common Iliac Artery Lesions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Common Iliac Artery Lesions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Severe Calcified Artery Lesions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Severe Calcified Artery Lesions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Severe Calcified Artery Lesions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Complete Obstructive Artery Lesions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Complete Obstructive Artery Lesions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Complete Obstructive Artery Lesions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• JAPAN
  • Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• CHINA
  • Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• EUROPE
  • Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Iliac Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Iliac Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Iliac Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• FRANCE
  • Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• GERMANY
  • Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 107: UK Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Iliac Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Iliac Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Iliac Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• INDIA
  • Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 164: India Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Iliac Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Iliac Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Iliac Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Iliac Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Iliac Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Iliac Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• AFRICA
  • Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION